Applied Biosystems Completes Acquisition of the Research Products Division of Ambion
News Mar 03, 2006
"We are excited about the many opportunities for sales growth and new products that we anticipate as a result of this strategic acquisition," said Catherine M. Burzik, president of Applied Biosystems.
"We welcome Ambion's employees and anticipate a smooth integration of product lines and personnel as we accelerate the delivery of more complete workflow solutions to our global customer base."
The research and development, manufacturing, and other operations of Ambions Research Products Division will continue to be based in Austin, Texas and its approximately 300 employees will be integrated into the Applied Biosystems global workforce of approximately 4,000 employees.
Ambion will become a center of excellence within the Molecular Biology Divisions consumables business with a focus on expanding the range of consumables products in the Applied Biosystems portfolio.
Recent Ambion product introductions include reagents associated with microRNA and RNA interference.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Gene Regulator May Contribute to Protein Pileup in Exfoliation GlaucomaNews
Researchers are seeking factors that contribute to protein pileup in exfoliation glaucomaREAD MORE
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE